Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TRCS CPRV
- Development stage
- Unknown
- Lead developer
- Queen Saovabha Memorial Institute
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Intradermal
01
Overview
TRCS CPRV is an inactivated cell culture-purified rabies vaccine (CPRV) developed and manufactured by the Queen Saovabha Memorial Institute (QSMI) of the Thai Red Cross Society, in collaboration with BioNet-Asia and Liaoning Cheng Da Biotechnology. It is produced using purified cell culture technology and is indicated for both pre-exposure and post-exposure prophylaxis (PEP) against rabies virus infection. The vaccine is widely distributed in Thailand and ASEAN countries. Beyond its clinical use for prevention, it is the subject of immunological research investigating the effects of frequent booster vaccinations on immune memory and tolerance, specifically monitoring regulatory T cells, B cells, and neutralizing antibody titers to ensure long-term efficacy and safety in populations requiring frequent immunization.
- Brand names
- TRCS CPRV
- Other names
- Thai Red Cross Society Cell Purified Rabies VaccineRabies vaccine (Queen Saovabha Memorial Institute)QSMI rabies vaccinerabies vaccine-Queen Saovabha Memorial Institute-rabies
02
Targets
RABV-G (Rabies virus glycoprotein)Rabies virus antigen
Beyond the preview
Go deeper on TRCS CPRV.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TRCS CPRV.